ECSP045048A - NEW ORAL SOLID DOSAGE FORM OF 5- [2-ETOXI- 5 (4-METHYLIPERAZIN-1-IL SULFONYL) PHENYL] -1,6-DIHYDRO-1-METHYL-3-PROPYLPIRAZOL [4,3-D] PIRIMIDIN- 7-ONA CITRATE AND PROCESS FOR MANUFACTURING - Google Patents
NEW ORAL SOLID DOSAGE FORM OF 5- [2-ETOXI- 5 (4-METHYLIPERAZIN-1-IL SULFONYL) PHENYL] -1,6-DIHYDRO-1-METHYL-3-PROPYLPIRAZOL [4,3-D] PIRIMIDIN- 7-ONA CITRATE AND PROCESS FOR MANUFACTURINGInfo
- Publication number
- ECSP045048A ECSP045048A ECSP045048A ECSP045048A EC SP045048 A ECSP045048 A EC SP045048A EC SP045048 A ECSP045048 A EC SP045048A EC SP045048 A ECSP045048 A EC SP045048A
- Authority
- EC
- Ecuador
- Prior art keywords
- sulfonyl
- dihydro
- citrate
- phenyl
- methyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 title 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical class O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008184 oral solid dosage form Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000007910 chewable tablet Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención está dirigida a un nuevo producto farmacéutico y a su proceso de fabricación. Más particularmente, la presente invención se refiere a una nueva forma sólida de dosificación oral que contiene 5- [2-etoxi- 5(4-metilpiperazin-1-il sulfonil) fenil]-1,6-dihidro -1-metil-3-propil pirazolo [4,3-d] pirimidin-7-ona citrato, como agente activo, en compañía de excipientes farmacéuticamente aceptables, entregados en tabletas masticables, y al proceso de fabricación de estas formas de dosificación.The present invention is directed to a new pharmaceutical product and its manufacturing process. More particularly, the present invention relates to a novel solid oral dosage form containing 5- [2-ethoxy-5 (4-methylpiperazin-1-yl sulfonyl) phenyl] -1,6-dihydro -1-methyl-3 -propyl pyrazolo [4,3-d] pyrimidin-7-one citrate, as an active agent, in the company of pharmaceutically acceptable excipients, delivered in chewable tablets, and to the manufacturing process of these dosage forms.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CO03029961A CO5330617A1 (en) | 2003-04-09 | 2003-04-09 | NEW ORAL SOLID DOSAGE FORM OF 5- [2-ETOXI-5 (4-METHYLPIPERAZIN-1-IL SULFONYL) PHENYL] -1,6-DIHYDRO-1-METHYL-3-PROPYLPIRAZOL [4,3-D] PIRIMIDIN- 7-ONA CITRATE AND PROCESS FOR MANUFACTURING |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045048A true ECSP045048A (en) | 2004-05-28 |
Family
ID=40435089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP045048 ECSP045048A (en) | 2003-04-09 | 2004-04-06 | NEW ORAL SOLID DOSAGE FORM OF 5- [2-ETOXI- 5 (4-METHYLIPERAZIN-1-IL SULFONYL) PHENYL] -1,6-DIHYDRO-1-METHYL-3-PROPYLPIRAZOL [4,3-D] PIRIMIDIN- 7-ONA CITRATE AND PROCESS FOR MANUFACTURING |
Country Status (4)
| Country | Link |
|---|---|
| CO (1) | CO5330617A1 (en) |
| EC (1) | ECSP045048A (en) |
| GT (1) | GT200400059A (en) |
| PE (1) | PE20050017A1 (en) |
-
2003
- 2003-04-09 CO CO03029961A patent/CO5330617A1/en not_active Application Discontinuation
-
2004
- 2004-03-31 GT GT200400059A patent/GT200400059A/en unknown
- 2004-04-06 EC ECSP045048 patent/ECSP045048A/en unknown
- 2004-04-07 PE PE2004000358A patent/PE20050017A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5330617A1 (en) | 2003-10-31 |
| PE20050017A1 (en) | 2005-02-24 |
| GT200400059A (en) | 2005-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05007643A (en) | Method for producing an immediately decomposing oral form of administration which releases active ingredients. | |
| UY27277A1 (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A UNIFORM DISTRIBUTION AND POWER OF THE DRUG | |
| WO2006106514A3 (en) | Electrospun dosage form and method of producing the same | |
| WO2005046640A3 (en) | Multi-site drug delivery platform | |
| CY1112256T1 (en) | PHARMACEUTICAL DOSAGE FORMING CONTAINERS AND METHOD OF PREPARATION | |
| WO2008035020A3 (en) | Galenic form for the trans-mucosal delivery of active ingredients | |
| UY27886A1 (en) | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO. | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| WO2005097076A3 (en) | Low dose pharmaceutical products | |
| AR034813A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME | |
| ECSP066553A (en) | MASTICABLE ADMINISTRATION FORMS, NOT INDIVIDUALLY DOSED COMPRESSED. | |
| ATE262893T1 (en) | DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| PA8548301A1 (en) | PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION | |
| SG160391A1 (en) | Cladribine regimen for treating multiple sclerosis | |
| ECSP045048A (en) | NEW ORAL SOLID DOSAGE FORM OF 5- [2-ETOXI- 5 (4-METHYLIPERAZIN-1-IL SULFONYL) PHENYL] -1,6-DIHYDRO-1-METHYL-3-PROPYLPIRAZOL [4,3-D] PIRIMIDIN- 7-ONA CITRATE AND PROCESS FOR MANUFACTURING | |
| TW200420304A (en) | Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction | |
| MY153713A (en) | A pharmaceutical composition comprising 3, 4-dihydro-3-methyl-4-oxoimidazo [5,1-d]-1,2,3,5-tetrazine-8-carboxylate | |
| MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
| UY27596A1 (en) | ORAL FORMULATION OF PURISIMATE FLUDARA WITH RAPID RELEASE OF INGREDIENT | |
| PT1499278E (en) | IMMEDIATE RELEASE PHARMACEUTICAL FORM FOR COMPOSITION OF TIBOLONE POLYMER | |
| ECSP034769A (en) | PHARMACEUTICAL COMPOSITION | |
| ZA200509322B (en) | Oral pharmaceutical formulations comprising acid-labile active ingredients and water-soluble sugar derivate, use thereof and the suitable process for manufacturing these | |
| CR7117A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO | |
| ECSP024290A (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME | |
| MY145885A (en) | Controlled release formulations for oral administration |